Accelerating Translational Impact: Integrated Biomarker Strategies

Unlock the full potential of biomarker-driven research with the power of Olink™ technology. Join us for this webinar, as we explore how proteomics is transforming translational science – bridging preclinical insights and clinical outcomes with greater confidence. Discover how integrated datasets can accelerate decision-making, de-risk development programs, and drive meaningful impact.

Hear from Julien Peladan from Evotec, an Olink™ Certified Service Provider, as he presents cutting-edge applications across liver and autoimmune diseases, showcasing how multiomics approaches enable deeper biological understanding and advance precision medicine.

What you will learn:

• How Olink^TM technology integrates seamlessly into multimodal biomarker strategies to enhance translational success.
• Why combining proteomics with other omics layers improves biomarker discovery, validation, and clinical decision-making.
• How real-world applications-from preclinical models to patient cohorts enable robust biomarker identification and patient stratification.

Study Insights

Evotec, in collaboration with Esperion showcases a rare liver disease program where combined scRNA-seq and Olink^TM technology protein profiling enabled the identification and cross-species validation of a robust pharmacodynamic biomarker - from mouse models to human samples.

You will also hear about the Evotec Autoimmune Disease Initiative, where Olink^TM technology, alongside metabolomics and lipidomics, uncovered novel immune mediators and enabled precise patient stratification across multiple autoimmune conditions.

Speakers